50°
Oxford University researchers found that the number of people who receive blood clots after getting vaccinated is approximately the same for all three vaccines, with four in one million people experiencing cerebral venous thrombosis (CVT) after getting the Pfizer or Moderna vaccine, compared to five in one million people for the AstraZeneca vaccine.
The new study comes in the wake of AstraZeneca’s vaccine use being halted or limited in several countries due to concerns of blood clots that have recently been reported in patients getting vaccinated.
On Tuesday, April 13 the Food and Drug Administration and the Centers for Disease Control and Prevention advised states to temporarily “pause" the use of Johnson & Johnson vaccines “out of an abundance of caution” after six women developed a rare blood-clotting disorder that left one dead and one in critical condition.
The complete Oxford University study can be found here.
Click here to follow Daily Voice Drexel Hill-Upper Darby and receive free news updates.
